BCE-T
B C E INC
stock TSE

# 🚀 Top Gainers
|Symbol|Company Name|Last Price (CAD)|% Change|
|:-|:-|:-|:-|
|[CTS-T](https://wealthawesome.com/stock/cts-to/)|Converge Technology Solutions Corp|$5.41|🟩 **+53.26%**|
|[TNZ-T](https://wealthawesome.com/stock/tnz-to/)|Tenaz Energy Corp|$15.25|🟩 **+10.91%**|
|[ILLM-T](https://wealthawesome.com/stock/illm-to/)|AcuityAds Holdings Inc|$2.87|🟩 **+6.30%**|
|[ECO-T](https://wealthawesome.com/stock/eco-to/)|EcoSynthetix Inc|$4.73|🟩 **+6.29%**|
|[MSA-T](https://wealthawesome.com/stock/msa-to/)|Mineros S.A.|$2.10|🟩 **+5.53%**|
# 📉 Top Losers
|Symbol|Company Name|Last Price (CAD)|% Change|
|:-|:-|:-|:-|
|[MUX-T](https://wealthawesome.com/stock/mux-to/)|McEwen Mining Inc|$10.54|🟥 **-15.00%**|
|[BCT-T](https://wealthawesome.com/stock/bct-to/)|Briacell Therapeutics Corp|$5.35|🟥 **-7.28%**|
|[TC-T](https://wealthawesome.com/stock/tc-to/)|Tucows Inc|$21.07|🟥 **-6.69%**|
|[BCE-T](https://wealthawesome.com/stock/bce-to/)|BCE Inc|$31.62|🟥 **-6.17%**|
|[OTEX-T](https://wealthawesome.com/stock/otex-to/)|Open Text Corp|$39.77|🟥 **-5.89%**|
# 📌 Market Highlights
**Converge Technology Solutions Corp (CTS-T)**
* **Strategic Acquisition:** Converge announced the acquisition of a leading cloud services provider, significantly enhancing its service offerings and market reach.
**Tenaz Energy (TNZ-T)**
* **Analyst Upgrades:** National Bank Financial initiated coverage on Tenaz Energy with an Outperform rating and a C$23.00 price target, citing its strong leadership under CEO Anthony Marino and a strategic acquisition approach focused on undercapitalized assets. The firm highlighted Tenaz's global expansion strategy, particularly in Europe, South America, the Middle East, and North Africa
**McEwen Mining Inc (MUX-T)**
* **Private Placement:** Recently announced a private placement of $95 million in convertible senior notes, leading to a 13.2% decline in its stock price due to investor concerns over potential dilution
**Briacell Therapeutics Corp (BCT-T)**
* **Clinical Trial Update:** On February 3, 2025, BriaCell shared results from its metastatic breast cancer trial, highlighting a clinical response in a patient treated with its Bria-OTS immunotherapy. Despite this positive outcome, the stock experienced a 4.71% decline, possibly due to broader market reactions or investor expectations

# 🚀 Top Gainers
|Symbol|Company Name|Last Price (CAD)|% Change|
|:-|:-|:-|:-|
|[CTS-T](https://wealthawesome.com/stock/cts-to/)|Converge Technology Solutions Corp|$5.41|🟩 **+53.26%**|
|[TNZ-T](https://wealthawesome.com/stock/tnz-to/)|Tenaz Energy Corp|$15.25|🟩 **+10.91%**|
|[ILLM-T](https://wealthawesome.com/stock/illm-to/)|AcuityAds Holdings Inc|$2.87|🟩 **+6.30%**|
|[ECO-T](https://wealthawesome.com/stock/eco-to/)|EcoSynthetix Inc|$4.73|🟩 **+6.29%**|
|[MSA-T](https://wealthawesome.com/stock/msa-to/)|Mineros S.A.|$2.10|🟩 **+5.53%**|
# 📉 Top Losers
|Symbol|Company Name|Last Price (CAD)|% Change|
|:-|:-|:-|:-|
|[MUX-T](https://wealthawesome.com/stock/mux-to/)|McEwen Mining Inc|$10.54|🟥 **-15.00%**|
|[BCT-T](https://wealthawesome.com/stock/bct-to/)|Briacell Therapeutics Corp|$5.35|🟥 **-7.28%**|
|[TC-T](https://wealthawesome.com/stock/tc-to/)|Tucows Inc|$21.07|🟥 **-6.69%**|
|[BCE-T](https://wealthawesome.com/stock/bce-to/)|BCE Inc|$31.62|🟥 **-6.17%**|
|[OTEX-T](https://wealthawesome.com/stock/otex-to/)|Open Text Corp|$39.77|🟥 **-5.89%**|
# 📌 Market Highlights
**Converge Technology Solutions Corp (CTS-T)**
* **Strategic Acquisition:** Converge announced the acquisition of a leading cloud services provider, significantly enhancing its service offerings and market reach.
**Tenaz Energy (TNZ-T)**
* **Analyst Upgrades:** National Bank Financial initiated coverage on Tenaz Energy with an Outperform rating and a C$23.00 price target, citing its strong leadership under CEO Anthony Marino and a strategic acquisition approach focused on undercapitalized assets. The firm highlighted Tenaz's global expansion strategy, particularly in Europe, South America, the Middle East, and North Africa
**McEwen Mining Inc (MUX-T)**
* **Private Placement:** Recently announced a private placement of $95 million in convertible senior notes, leading to a 13.2% decline in its stock price due to investor concerns over potential dilution
**Briacell Therapeutics Corp (BCT-T)**
* **Clinical Trial Update:** On February 3, 2025, BriaCell shared results from its metastatic breast cancer trial, highlighting a clinical response in a patient treated with its Bria-OTS immunotherapy. Despite this positive outcome, the stock experienced a 4.71% decline, possibly due to broader market reactions or investor expectations